KRSITF
ALNY icon

Kentucky Retirement Systems Insurance Trust Fund’s Alnylam Pharmaceuticals ALNY Stock Holding History

Kentucky Retirement Systems Insurance Trust Fund’s Portfolio ALNY Stock Details ALNY Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$1.09M Hold
3,285
– – 0.07% 241
2025
Q4 		$1.31M Hold
3,285
– – 0.08% 208
2025
Q3 		$1.5M Sell
3,285
-218
-6% -$88.8K 0.1% 188
2025
Q2 		$1.14M Sell
3,503
-243
-6% -$67.2K 0.08% 236
2025
Q1 		$1.01M Buy
+3,746
New +$963K 0.07% 252

Other funds holding ALNY

Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Capital World Investors
Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Capital Research Global Investors
Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return
VPM
Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
T. Rowe Price Investment Management
T. Rowe Price Investment Management Baltimore, Maryland $145B AUM 22.78% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Kentucky Retirement Systems Insurance Trust Fund's ALNY Position: Q1 2026 in Review

Kentucky Retirement Systems Insurance Trust Fund held its Alnylam Pharmaceuticals (ALNY) position steady in Q1 2026 at 3,285 shares worth $1.09M. The position accounts for 0.07% of the portfolio, ranked #241.

Kentucky Retirement Systems Insurance Trust Fund first reported a position in ALNY in Q1 2025 and has held it in 5 quarters since. The position peaked at $1.5M in Q3 2025. 787 funds tracked by Wall St. Rank hold ALNY as of Q1 2026.

  • Kentucky Retirement Systems Insurance Trust Fund held 3,285 shares of Alnylam Pharmaceuticals worth $1.09M as of Q1 2026.
  • Kentucky Retirement Systems Insurance Trust Fund left its Alnylam Pharmaceuticals share count unchanged in Q1 2026.
  • Alnylam Pharmaceuticals made up 0.07% of Kentucky Retirement Systems Insurance Trust Fund's portfolio in Q1 2026, its #241 holding.
  • Kentucky Retirement Systems Insurance Trust Fund first reported a position in Alnylam Pharmaceuticals in Q1 2025 and has held it in 5 quarters since.
  • Kentucky Retirement Systems Insurance Trust Fund's Alnylam Pharmaceuticals position peaked at $1.5M in Q3 2025.
  • 787 funds tracked by Wall St. Rank held Alnylam Pharmaceuticals as of Q1 2026.

Based on Kentucky Retirement Systems Insurance Trust Fund's 13F filing for Q1 2026, filed 19 May 2026.